Analysis of the legal issues with the current IP system for regulated market authorisations for pharmaceutical products, as well as its economic effects.
Scholars have devoted much research to the “productivity puzzle” that has emerged after the crisis, and some are investigating the role of financial frictions and capital allocation in relation to this phenomenon.
Chinese R&D investment has grown remarkably over the past two decades. It is now the second-largest performer in terms of R&D spending, on a country basis, and accounts for 20 percent of total world R&D expenditure, with the rate of R&D investment growth greatly exceeding that of the U.S. and the EU.
At this event Bruegel, together with EIB and the World Economic Forum will launch a White Paper on inclusive growth and competitiveness in Europe.
The EFIGE dataset on firms' competitivenes was recently updated by extending the panel-level balance sheet data until the year 2014. This post highlights the main features of the brand new data.
Micro-economic features of economic systems can have a major impact on national performance. Policymakers should therefore reconfigure their scoreboards to reflect the roles played in a country’s economic growth by large internationalized firms, global value chains or resource reallocation.
Making the manufacturing sector more competitive is vital to restore economic growth in Europe. Changing business models to sell services as well as products can provide useful revenue to manufacturers.